Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Xenon Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 15.5K | Jun 5, 2024 | Direct | ||
GW PHARMACEUTICALS PLC | Chief Executive Officer, Director | Ordinary Shares | 0 | May 5, 2021 | By Justin D. Gover 2020 Irrevocable Trust dated December 14, 2020 | ||
GW PHARMACEUTICALS PLC | Chief Executive Officer, Director | Ordinary Shares | 0 | May 5, 2021 | By the Gover Family Investment LLP | ||
GW PHARMACEUTICALS PLC | Chief Executive Officer, Director | Ordinary Shares | 0 | May 5, 2021 | Direct | ||
GW PHARMACEUTICALS PLC | Chief Executive Officer, Director | Share Options | 0 | May 5, 2021 | Direct | ||
Xenon Pharmaceuticals Inc. | Director | No securities are beneficially owned. | 0 | Aug 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XENE | Xenon Pharmaceuticals Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Director |
XENE | Xenon Pharmaceuticals Inc. | Aug 10, 2023 | 1 | $0 | 4 | Aug 10, 2023 | Director |
XENE | Xenon Pharmaceuticals Inc. | Aug 8, 2023 | 0 | $0 | 3 | Aug 10, 2023 | Director |
GWPH | GW PHARMACEUTICALS PLC | May 5, 2021 | 19 | $0 | 4 | May 7, 2021 | Chief Executive Officer, Director |